Saturday, October 10, 2009
Influenza, antibiotics, and procalcitonin
So what's this got to do with antibiotics? Nothing that we knew about back when I was in med school, I can assure you of that. An article and editorial in a September issue of JAMA(1), therefore, was quite an eye-opener on just how important it is to continue on with continuing medical education.
First, a word or two about lower respiratory tract infections (LTRI) and antibiotic use, a subject that impacts my patients and my decision-making processes every day, especially as swinish flu slams the Denver area. Why do I closet myself several times an hour with some miserable coughing wretch at great personal risk to my own lower respiratory tract? To distinguish ordinary, show-stopping/week-ruining influenza from its many complications, particularly secondary bacterial bronchitis and pneumonia. Often it's me (don't want to overprescribe antibiotics to avoid complications to the patient and antibiotic resistance to the public) vs. them (No time for this! Need antibiotics! Big test/presentation/trip/wedding coming up! Need antibiotics!).
I check out: how sick are they, how long have they been sick, are they having trouble breathing, is their O2 level low, how do their lungs sound, what color are their secretions. Knowing all the while that they feel miserably sick, any days with flu are too many days, their airways are swollen so of course they feel short of breath, and, of course, their secretions are doubtless gross because flu-sloughed cells in the airway plus gobs of white cells will make that which they hack out green.
Surely there must be a better formula other than my experience + intuition + observations. Enter procalcitonin(PCT), and it's not just for regulating calcium anymore. While the thyroid C-cells make PCT and turn it into calcitonin depending on the biochemical need to drop calcium levels in the blood, all sorts of other tissues release PCT when the body is fighting bacterial attack. Under normal conditions, PCT is barely detectable in the blood but levels can soar 100,000-fold with widespread sepsis as bacteria invade the bloodstream.
So here we have a wonderful demonstration of theragnostics (another concept that's new to me) wherein a diagnostic test--say PCT levels--identifies patients likely to be helped by a certain therapy, and then targeted drug therapy is given--e.g.antibiotics--based on those results. And I, with my expensive cognitive skills, am cut out of the equation thus making therapy not only more scientific and less intuitive, but also more accessible and affordable!
Now of course this is not yet anything you'll find in a Walgreen's TakeCare Clinic (until perhaps a handheld PCT-O-Meter is developed) but the possibilities are exciting. Not only could we know just when to treat acute bronchitis or pneumonia with antibiotics because PCT levels indicate a bacterial source, we could use this test in other puzzling situations such as whether or not artificial joints are infected or a patient with worsening chronic lung disease has an infectious complication.
_____
1) Schuetz, P et al. Effect of Procalcitonin-Based Guidelines vs Standard Guidelines on Antibiotic Use in Lower Respiratory Tract Infections. JAMA Sept. 9, 2009 Vol 302, No. 10 1059-1066.
Sunday, October 04, 2009
Emotion and Memory
I can tell you the exact spot I pulled over, the weather, and where I had been. This all quite remarkable as, on average, I've a big picture sort of mind while the details leak before storage in long-term brain files (no surprise this to my husband). My friend later told me that everyone invariably related the minutiae of the moment in which they'd heard of her rescue--this after I'd supplied her with my experience as if it were the most fascinating tale.
So what's with this emotional boost to memory? If you were alive at the time, you can doubtless remember where you were when Kennedy was shot or the moon landing occurred. Likewise for the World Trade Center tragedy and perhaps Princess Diana's death.
Japanese neuroscientists studied emotion and memory in patients with Alzheimer's Disease (AD) following the devastating Kobe earthquake of 1995.(1) They performed brain MRIs on all the subjects, then checked out who remembered the earthquake and who remembered the MRI. The patients were much more likely to remember the quake, suggesting that intense emotions reinforced the memory.
The researchers went on to correlate the ability to remember the temblor with the residual size of the subjects' hippocampus (the brain's memory center) and amygdala (emotional center). Victims of AD are known to suffer from brain shrinkage. Those who retained the emotional memory of waking up to a significant earthquake were much more likely to have a normal-sized amygdala no matter the size of their hippocampus, and, likewise, those with impaired emotional event memory had more intense amygdalar damage.
_____
1)Kazui, H. Emotion and memory. Four studies of the emotional memory in Alzheimer's disease. Japanese Journal of Neuropsychology. VOL.18;NO.3;PAGE.150-156(2002).
Wednesday, September 30, 2009
Can Prednisone make me feel crazy?
Sunday, September 27, 2009
Advanced glycation end products
These advanced glycation end products or AGE are the end-products of reactions that bond sugar to protein in the absence of water. Think sugar steaks (too bad you won't want to try one at Bastien's Steak House on Colfax after reading this), the brown sugar/Jack Daniels crust on baked ham, browned cookies, the caramelized surface of creme brulee. So let's just say you avoid AGE in foods, and I'm not necessarily saying you should because, after all, life is meant to be enjoyed, well turns out you can glycate your own darn sugar once its ingested or produced. And fructose (that which sweetens your bottled drinks) is very prone to glycation.
So AGE along with ALE (that would be advanced lipoperoxidation end products or metabolized fat) are very proinflammatory molecules. AGE hooks up with specific cellular receptors called RAGE and the combo acts as a 'master switch' that activates nuclear factor kappaB(1) and creates high levels of dysfuntional proteins among other things. The sort of dysfunctional proteins that gum up your brain, your peripheral nerves, and your arteries.
Well we're all going to rust and glycate and peroxidate eventually, and we may as well do it with the satisfied smile of the occasional gourmand. But, as in all things, a little is good but a lot is not, and if you want to keep your cells functional, some things are best done in moderation or not at all.
_____
1) NF-kB is a good thing if you happen to be injured or infected as it amplifies the immune response but a bad thing if you happen to drink Coke and eat browned chocolate chip cookies on a regular basis.
Tuesday, September 22, 2009
New Diagnoses, New Behavior
Once more you're running around in circles just to prove
You knew the answers all the while
Can't figure why no matter what you say or do
Things stay the same you will remain
Day late a dollar short
Day late a dollar short
--The Acro-Brats(1)
There's nothing like a new diagnosis of diabetes to get a patient's attention. Suddenly, all those discussions about diet, exercise, weight loss, soda consumption, etc. make sense. Well better late than never (perhaps The A-B's have a song about that too) but there's also the day late dollar short thing too because this is a condition that you are far better off without.
Yale scientists actually set out to prove what I already knew from years of consultations with the newly diagnosed. They checked out data from the Health and Retirement Study panel on over 20,000 people who were overweight or smokers.(2) The odds of weight loss or smoking cessation were hugely increased among individuals newly diagnosed with serious illnesses such as diabetes, smoking, heart disease, or COPD. Those who'd just learned they had heart disease were 5 times more likely to throw away the smokes than persons just counseled to do so just because it was the right thing to do, and new diabetics sent their BMI's plunging compared to the merely overweight.
Can't figure why no matter what I say or do
Things stay the same patients will remain
Day late a dollar short
Day late a dollar short
_____
(1) I actually listened to this song on You-Tube. Definitely not my thing--the metallic thrum made my amygdala cringe-- but I appreciate the edgy frustration expressed by the Acro-Brats. I feel it myself, everyday, in exam room encounters.
(2) Keenan, PS. Smoking and weight change after new health diagnoses in older adults. Arch Intern Med. 2009 Feb 9;169(3):237-42.
Sunday, September 20, 2009
Too close for comfort?
I recently attended my 40th high school reunion. I talked for awhile with one old friend I hadn't seen in years. But I was distracted during the entire conversation by her preferred conversational distance which was close, darned close! Not a breath problem--hers was fine and apparently mine was too--just my problem with her 'in my face' proximity. A new study may indicate why, and it implicates my overactive amygdala.I've mentioned before that the amygdala, an almond-sized region at the base of the brain, is nerve cell center for coordinating response to threat. If yours is on overdrive like mine, you may over-respond to horror movies, scary books, and phones ringing in the night.
Neuroscientists had the opportunity to study the biological underpinnings of personal space in a patient known as SM. She had a genetic disorder that took out her amygdala, and as a result, she could not recognize fearful facial expressions in others, and was very outgoing and far more trusting than average. And she cozied up in conversational situations such that she--Ms. Red above--let an experimenter get twice as close to her as the other Ms. Blues did without expressing any discomfort in the situation. (1)
Scientists went on to study preferred conversational distance with functional MRI scanning.(2) They socked away average persons with intact amygdalae in the machine, then got closer and closer to the subjects, measuring their brains for activity. When they invaded that person's comfort zone, the amygdala lit up with activity.
"Our findings support the idea that the amygdala functions as the brakes in social interactions, If you take away the amygdala, it seems like you are less tuned to ... social [behaviors] that can cause discomfort," says neuroscientist Richard Davidson of the University of Wisconsin.(1)
_____
1) ScienceNOW Daily News, August 31, 2009
2) Kennedy DP et al. Personal Space Regulation by the Human Amygdala. Nat Neurosci 2009 Aug 30.
Thursday, September 17, 2009
Antibiotic resistance and beyond
--George Church, geneticist, Harvard Medical School
What's eating you may eat drugs too! Church and company dug up this unhappy piece of news while digging in a cornfield fertilized with manure from antibiotic-fed cows. They compared the locals (soil microbes) in the corn patch to their bacterial colleagues from the dirt of a pristine forest and several other locales more or less contaminated with druggish waste.
So you'd expect those bugs inured to manure to be antibiotic resistant and the au naturel bunch to die when cultured with drugs, right? Unfortunately, wrong. Bacteria from every sampling included strains that could survive "with nothing to eat but antibiotics." Not only did these little hummers not die from the drugs, they devoured them.
For those of us who think antibiotic resistance is not a huge and looming danger, Gerry Wright, a chemical biologist from McMaster University, sums it up in words that can't be ignored: "Soil bacteria pass around resistance-conferring genes like teenagers swap downloaded music files, and pathogenic [disease-causing] bacteria could likewise pick up antibiotic-digesting genes, particularly from a closely related microbe.
Great.
Tuesday, September 15, 2009
Health care debate
Denver Doc now on Twitter
If you're interested in Twitter updates from Denver Doc Online, you can sign-up at
www.twitter.com/docofages. Thanks!
Monday, September 14, 2009
The amygdala and PTSD

I can hardly bear to watch violent or scary movies. I walked out on The Ring the moment the dried-up little girl was found in the closet (thankfully, the movie was 'showing' at the time in our living room). And the opening scene of The Exorcist in which Father Merrin finds the creepy little statue, the wind blows, and a couple of dogs fight still can interfere with a good night's sleep for me.
Research suggests that an overactive amygdala (the brain's VP in charge of processing emotional experiences and fear) may predict how an individual handles stress, be it in pictures or for real. Israeli scientists used functional magnetic resonance imaging (fMRI) to scan the brains of 18 year old subjects undertaking training as paramedics(1). They scanned the trainee's brains while showing them photographs of graphic medical scenes specifically looking for activation in the amygdala region. They also screened the recruits for stress symptoms including anxiety and insomnia.
After 18 months and a grisly load of combat experience, the researchers found that those paramedics with the largest increases in stress symptoms were the ones with the greatest amygdaloid activity on the initial scan. Study co-author Talma Hendler says that the amygdala may be an "a priori biological marker" for individual susceptibility to post-traumatic stress disorder.
Rather than use a fancy, expensive fMRI as a screening test for fitness under fire, I suggest a less expensive showing of Inglorious Basterds. Check the subjects' heart rate and blood pressure by the movie's end, and you'll know who's ready for the field and who should stick to the office.
_____
1. Proc Natl Acad Sci USA. 2009 Aug 18;106(33):14120-5.
Thursday, September 10, 2009
H1N1 vaccine--one dose will do!
Vaccine demand is expected to exceed supply through the fall, so this one shot news is good news indeed.
Monday, September 07, 2009
Who should get Tamiflu for H1N1 flu?
There are 2 available antivirals which are active against 2009 A(H1N1)-- oral Tamiflu (oseltamivir) and inhaled Relenza (zanamivir). For some reason, I've always reached for Tamiflu, and a brief search for a comparison of one antiviral to the other suggests that I am just another victim of an effective marketing campaign by Roche Pharmaceuticals. Nevertheless, be it Tamiflu or Relenza, one of the biggest fears per flu-ologists is that the novel H1N1 flu will become resistant to these worthy drugs, and they will be rendered powerless against the bug.
So what does the CDC have to say on the subject? They along with the WHO (the World Health Organization, that is, not the '60's band) recommend that antiviral treatment be undertaken in accord with the following guidelines:
- Treatment is recommended for all hospitalized patients with confirmed, probable or suspected 2009 H1N1 or seasonal influenza.
- Treatment generally is recommended for patients who are at higher risk for influenza-related complications.
- Treatment should be initiated empirically when the decision is made to treat patients who have illnesses that are clinically compatible with influenza. Treatment should not await laboratory confirmation because laboratory testing can sometimes delay treatment and because a negative rapid test does not rule out influenza.(1)
These recommendations highlight the urgency with which certain subgroups of flu victims should be treated. The CDC, therefore, goes on to make further suggestions as to handle the upcoming flu season and the avalanche of requests for antiviral medications. These include:
- Provide information for patients at higher risk for influenza complications about signs and symptoms of influenza and need for early treatment after symptom onset.
- Ensure rapid access to telephone consultation and clinical evaluation for these patients as well as patients who report severe illness.
- Consider empiric treatment of patients at higher risk for influenza complications based on telephone contact... if this will substantially reduce delay before treatment is initiated. In selected circumstances, providers may consider giving a prescription for an influenza antiviral to selected patients who are higher risk for influenza complications.
- Request that patients at higher risk for influenza complications contact the provider if signs or symptoms of influenza develop, obtain the medication as quickly as possible and initiate treatment.
- Counsel patients about influenza antiviral benefits and adverse effects, the potential for continued susceptibility to influenza virus infection after treatment is completed (because of other circulating influenza viruses or if illness was due to another cause).(2)
- Persons who are at higher risk for complications of influenza and are a close contact of a person with confirmed, probable, or suspected 2009 H1N1 or seasonal influenza during that person’s infectious period.
- Health care personnel, public health workers, or first responders who have had a recognized, unprotected close contact exposure to a person with confirmed, probable, or suspected 2009 H1N1 or seasonal influenza during that person’s infectious period.
- Antiviral agents should not be used for post exposure chemoprophylaxis in healthy children or adults based on potential exposures in the community, school, camp, etc.
- Chemoprophylaxis generally is not recommended if more than 48 hours have elapsed since the last contact with an infectious person.
1. http://www.cdc.gov/h1n1flu/recommendations.htm
2. This is an abbreviated list. See above web-site for the full printed version.
Friday, September 04, 2009
H1N1 and severe respiratory failure

Scientists are ferreting out clues to the ferocity with which this new swinish flu attacks the lower airways in some of its victims. Ferrets demonstrate a susceptibility to influenza A very similar to humans and therefore are used as an animal model in flu investigations.
The above picture(1) shows microscopic sections of ferret airways (that is not a goose!), comparing seasonal H1N1 flu (the usual variety that circulates each winter season) on the left to tissue infected by the 2009 A/H1N1 flu on the right. Violet coloration indicates affected surface cells, and both varieties make a mess out of noses with sloughing sheets of dead nasal tissue full of violet-colored intruders as seen in the top pair of slides.
Moving on down to the trachea (which is the largest central airway lined with rings of cartilage that you can feel in the front of your neck), the ferret with seasonal flu middle picture on left is free of viral invasion but the swine-flu ferret victim on the right has dots of violet flu violation throughout its trachea. Finally, and of importance to this discussion, slides from the bronchioles of both ferrets are pictured at the bottom. This tissue was obtained from the smallest airways that go directly into the alveolae or air sacs that hook up oxygen with blood. Seasonal Flu Ferret has normal bronchioles, flu bug free, but Swine Flu Ferret's tiny air passages are teeming with the little buggers.
What's this got to do with the upcoming flu season? One of my patients, an ICU nurse, shared a disturbing report with me yesterday. She said that her unit has been busy this entire spring to summer with youngish patients suffering from severe swine flu-related bronchiolities (inflammation filling these airways with fluid) requiring ventilator support until the infection started to clear. Her information jibed with an August report from the World Health Organization entitled "Preparing for the second wave: lessons from current outbreaks." Per the WHO document:
"Clinicians from around the world are reporting a very severe form of disease, also in young and otherwise healthy people, which is rarely seen during seasonal influenza infections. In these patients, the virus directly infects the lung, causing severe respiratory failure. Saving these lives depends on highly specialized and demanding care in intensive care units, usually with long and costly stays."
This information highlights not only the importance of widespread immunization against the 2009 A/H1N1 flu (which creates so-called herd immunity, slowing down or preventing the lateral spread of flu from person-to-person due to the large number of vaccine-protected people) but also the paramount importance of immunizations for persons with underlying illnesses, particularly asthma, cardiovascular disease, diabetes, and immunosuppression.
_____
(1) Munster, VJ, et al. "Pathogenesis and Transmission of Swine-Origin 2009 A(H1N1) Influenza Virus in Ferrets." Science 24 July 2009: Vol. 325. no. 5939, pp. 481 - 483.
Tuesday, September 01, 2009
Why should I get a flu shot?
Well, there's a hack of a lot of flu coming our way. Consider this:- Flu viruses reproduce every 8 hours.
- That's a three times daily opportunity to meet and mate with other influenza viruses in the neighborhood.
- If seasonal A(H1N1) rolls in the tracheal hay (that's your airway!) with swine-origin 2009(H1N1), the latter could develop an even more effective way of passing from human to human.
Friday, August 28, 2009
H1N1 flu shots
More precisely, .0000005 ounce of prevention which is the teensy-weensy amount of killed viral material that scientists from the CDC, National Institutes of Health, and various licensed pharmaceutical companies inserted into syringes as they launched clinical trials of newly manufactured H1V1 vaccine earlier this month. They expect to analyze study results from mid-September to mid-October and then begin the first public immunization programs before Halloween. The trials will provide important information on the vaccine's safety, efficacy, and whether one or two doses are needed to provide optimal protection. (Study results released 9/10/09 indicated that one dose for adults is sufficient.)
We already know that H1N1 influenza, first identified in Mexico in late winter of this year, is the most common cause of flu-related illness throughout the world at this time. While this new viral strain continues to cause low-levels of new cases in all 50 states, it is currently 'widespread' in Maine and Alaska. But the regular flu season has not even started yet, and once the usual seasonal blend of influenzas A and B hits, we can expect a double whammy of flu-driven illness this fall into winter.
Quite a few of you have called our office with logistical questions about how best to protect yourselves and your families against this onslaught of respiratory crud. Here's the latest information:
What can we expect?
We know that H1N1 flu is quite contagious, easily passed person to person via contaminated secretions from coughs and sneezes, and able to survive on surfaces for up to 8 hours. While the initial reports from Mexico were quite disturbing with respect to the severity of illness caused by this strain, the illness lately has been acting a lot like seasonal flu. It does disproportionately affect persons under 60 and and can be unusually virulent in those under 25. Per Dr. Jay Butler of the CDC, "75% of the [H1N1]hospitalizations are in those aged under 49 and 60% of the deaths are in those under age 49." Studies showed that no young adults demonstrated circulating antibodies to H1N1 at the start of this pandemic whereas many older adults apparently encountered a similar influenza variety in the past and were found to have some immunity to this strain.
Experts are unable to estimate the community prevalence of H1N1 as many cases are too mild to come to medical attention. In addition, as H1N1 becomes more prevalent, the CDC no longer recommends that such mild cases be tested to confirm the presence of this specific virus.
As I've mentioned in previously posts, influenza is a tricky and changeable foe which can mutate rapidly. Thus far, thankfully, studies of the virus from recent cases in the southern hemisphere demonstrate no significant genetic change from northern cases investigated earlier this year.
What's the difference between H1N1 and the seasonal flu?
H1N1 is a novel strain originating in swine (but not caused by consumption of pork!) that developed in North American pigs through the mixing in their respiratory tracts of genetic material from swine, human, and avian flus. It is antigenically distinct from seasonal flu which means that its proteins and genetic material are completely different than the ordinary influenza types that circulate each winter season.
Will I need shots for both?
Absolutely. Separate shots will be available for seasonal and H1N1 flu. Preliminary information released in an online version of The New England Journal of Medicine 9/10/09 indicates one dose will be sufficient for adults; the proper dosing for children is not yet available.
The seasonal flu shot and the H1N1 shot can be taken on the same day--but different arms please! The seasonal shot is already available, however, whereas the first H1N1 vaccines will not be distributed until late October. While the optimal time to receive the seasonal flu shot is October or November to assure that immunity lasts through the entire season, the CDC currently recommends that persons receive the seasonal vaccine as soon as possible to assure that both flu shots can be administered to the largest number of people.
How can I get the H1N1 vaccine?
While the CDC was hopeful that ample vaccine would be available by October, production delays will slow delivery of adequate vaccine until later on in the year. For this reason, certain groups have been assigned top priority for the first wave of vaccinations, chosen due to their risk for more serious disease. These include:
- Pregnant women
- Persons who live with or provide care for infants aged <6>
- Health-care and emergency medical services personnel with direct patient contact
- Children aged 6 months--4 years, and
- Children and teens aged 5--18 years who have high risk medical conditions
What about college-aged children?
The CDC and universities are implementing various programs to limit the spread of H1N1 disease on campus. Some Colorado schools will offer alternative housing for dorm residents whose roommates become ill.
Stay tuned for up-to-date information on the use of anti-viral medications such as Tamiflu for H1N1 prevention and treatment.
Tuesday, August 25, 2009
Triple Reassortment Swine Influenza*
"Six of the eight genetic segments of this virus strain are purely swine flu and the other two segments are bird and human, but have lived in swine for the past decade."
---Raul Rabadan, PhD, computational biologist at Columbia University
And that is why pigs are dubbed "mixing bowls" for influenza viruses. While humans are susceptible to human influenza viruses and somewhat less so to the swine varieties (at least up until now), our airways don't provide particularly good handholds for those influenza subtypes that seek out birds. Pigs, on the other hand, have receptors on the surfaces of their tracheal cells that welcome strains from all three species. From porcine throats and lungs, therefore, emerge new flu varieties with the potential to cause dangerous human disease.
These new flus are called triple-reassortment swine influenza A viruses as they contain genetic material from bird, human, and pig influenza viruses. Until recently, the pigs of North America kept their flu to themselves with sporadic reports of human infections generally limited to those most exposed to pigs in their daily work. Now, however, with another flip of their surface proteins--and flu viruses reproducing every 8 hours have 3 opportunities per day to mix, match, and mutate their DNA in a promiscuous sort of way--the little swinish devils have brought these reassorted flus to human airways. Furthermore, this newest genetic triple threat passes easily from one infected human to another.
With all this mating and mutating, therefore, epidemiologists are finding it hard to predict what's in store as the swine flu (and it is a swine flu no matter what it's called, passed at first from live pigs not pork meat) makes it way back to the Northern hemisphere big time. Fortunately, vaccine production is underway, and immunization programs should begin next month. More on that soon.
Saturday, August 01, 2009
What's a Phase 6 pandemic?
Grim?!? Whoa, that's a pretty strong word. In this weekly flu update, we'll check out the ease with which the H1N1 (formerly known as swine) flu spreads from person to person, and why the CDC is hoping for a timely vaccine against the virus.
What's a Phase 6 pandemic?
Sounds serious, and indeed it is insofar as it speaks of the ease with which this little hummer spreads from one human to the next.
The World Health Organization (WHO) has developed a 6-tiered approach that classifies the worldwide threat from strains of animal influenza newly arrived in human airways. Each higher level indicates an increased penetrance of the virus into human populations. By Phase 6--the current global level of the H1N1 flu--the virus has shifted into a lean, mean, human-to-human infecting machine in at least two countries of one WHO region and with spread detected in at least one country of a different region. This particular influenza virus, therefore, reached Phase 5 once it spread from person to person in Mexico and the United States; its subsequent spring '09 appearance in the Southern hemisphere then raised the threat to level 6.
Experts agree so far that this variety of influenza has a 'substantially higher' rate of transmissibility than the usual seasonal flu although this in itself does not mean that it's more lethal.
So what's transmissibility and what's the H1N1 score?
Influenza is quite contagious as it thrives in infected respiratory secretions and effectively spreads those viral laden droplets into the environment via juicy sneezes and coughs. The smaller the droplet, the longer it floats through the air and the further it penetrates into the airway of the unlucky recipient who inhales it. If the virus is novel--meaning that large portions of the population have never encountered this particular bug before--the risk of contagion is even higher.
Epidemiologists express transmissibility as reproductive number (R0 or R-zero) which is the number of cases caused by one infected person. If the R0 is less than one, the disease fades away, whereas rising R0 numbers mean that the spread of the disease is increasingly harder to contain. Experts think that an R0 more than 2 renders such measures as closing schools and screening visitors from other countries for signs of the disease as virtually useless.
So what's the R0 of H1N1? Compared to the seasonal flu with an average R0 of 1.3, estimates for H1N1 vary between 1.3 to more than 2. Calculating an accurate R0 for novel H1N1 flu is very complicated considering the many unknowns about this pandemic such as the incubation time and the percentage of cases mild enough to escape official notice. But we must assume that H1N1 is sporting a fairly robust R0 considering its current worldwide status, and, for that reason, we desperately need a vaccine to slow the spread of infection.
Upcoming info
The important thing in containing this pandemic, therefore, is the development and widespread use of an effective vaccine. More on that subject next week.
Tuesday, July 21, 2009
The end of private health insurance?
It didn't take long to run into an "uh-oh" moment when reading the House's "health care for all Americans" bill. Right there on Page 16 is a provision making individual private medical insurance illegal.
When we first saw the paragraph Tuesday, just after the 1,018-page document was released, we thought we surely must be misreading it. So we sought help from the House Ways and Means Committee.
It turns out we were right: The provision would indeed outlaw individual private coverage. Under the Orwellian header of "Protecting The Choice To Keep Current Coverage," the "Limitation On New Enrollment" section of the bill clearly states:
"Except as provided in this paragraph, the individual health insurance issuer offering such coverage does not enroll any individual in such coverage if the first effective date of coverage is on or after the first day" of the year the legislation becomes law.
So we can all keep our coverage, just as promised — with, of course, exceptions: Those who currently have private individual coverage won't be able to change it. Nor will those who leave a company to work for themselves be free to buy individual plans from private carriers.
From the beginning, opponents of the public option plan have warned that if the government gets into the business of offering subsidized health insurance coverage, the private insurance market will wither. Drawn by a public option that will be 30% to 40% cheaper than their current premiums because taxpayers will be funding it, employers will gladly scrap their private plans and go with Washington's coverage.
The nonpartisan Lewin Group estimated in April that 120 million or more Americans could lose their group coverage at work and end up in such a program. That would leave private carriers with 50 million or fewer customers. This could cause the market to, as Lewin Vice President John Sheils put it, "fizzle out altogether."
What wasn't known until now is that the bill itself will kill the market for private individual coverage by not letting any new policies be written after the public option becomes law.The legislation is also likely to finish off health savings accounts.
Washington does not have the constitutional or moral authority to outlaw private markets in which parties voluntarily participate. It shouldn't be killing business opportunities, or limiting choices, or legislating major changes in Americans' lives.
A blogger from Maine, participating in a conference call with the President, said he kept running into the above article that claimed Section 102 of the House health legislation would outlaw private insurance. He asked: “Is this true? Will people be able to keep their insurance and will insurers be able to write new policies even though H.R. 3200 is passed?” President Obama replied: “You know, I have to say that I am not familiar with the provision you are talking about.”Friday, July 17, 2009
Bystolic testimonial
Here is an e-mail I received from Cheryl on her experience:
I have been using Bystolic for over a month. I love it. Not only is it controlling my anxiety and fast heart rate, my blood pressure is down and I have a generalized good feeling. Things don’t get me worked up like before. And, I’m breaking the 5mg in half. I did have to stop taking it in the evening because my sleep was restless. But, I start my day with a cup of coffee and half a Bystolic and it’s a good thing. I was reluctant after trying samples of Diovan that almost killed me. (Yuk on that one….Poison*).
If I had known how great I would feel on Bystolic, I would have taken it a long time ago. I’m not a pill-popper and dodge it, but this works! I am a health freak and have fought taking meds, but my doctor prescribed it for my racing heart. The benefits make my life happier and healthier.
*This is Cheryl's reaction to Diovan. It often works well for others, and is a good drug for hypertension.
Onsolis

My dear friend is dealing with enormous post-op pain following a prolonged surgery for a bowel blockage. She's still in the IV drip phase of pain control, snowed under by varying doses of ketamine, hydromorphone, and methadone. The surgical team has called in anesthesia and the pain team to help manage her case, so we are once again dealing with multiple docs who, we hope, are more than less keeping in touch with one another.
Ways to control pain that don't require swallowing pills are important to surgical pain control as well as in situations where oral meds aren't tolerated or aren't enough. I was interested, therefore, to learn today about Onsolis, newly approved by the FDA, as an entirely new approach to the problem. Onsolis uses BioErodible MucoAdhesive (BEMA®) drug delivery technology to deliver Fentanyl across the tissues of the inner cheek into the bloodstream. Up until now, Fentanyl has been available as a skin patch which sometimes causes local irritation and occasionally results in overdose if patients apply heat to the body area on which the patch is stuck.
Gotta be careful with these heavy duty narcotics though, they are not for the uninitiated or narcotic naive patient whose liver is not muscled up for processing these drugs. I once had a patient with dreadful arthritis in her neck. She was prescribed morphine for pain control, and in an effort to be painfree, took way more than she tolerated and died in respiratory arrest. For patients like my friend, however, who have been using narcotic analgesia for some time and cannot reliably use or absorb oral meds, this little patch may be a great boon to their comfort.


